Last reviewed · How we verify

NCT05761483: STEBINANSIED

Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.

Recruiting now Last updated 29 January 2026
What this trial tests

trial testing ERCP in Liver Transplant Disorder in 40 participants. Currently enrolling.

Timeline
12 March 2020
Primary endpoint
31 October 2026
1 January 2028

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date12 March 2020
Primary completion31 October 2026
Estimated completion1 January 2028
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

18 and older, any sex, with Liver Transplant Disorder or Ischemic Cholangiopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate the results of endoscopic treatment of NON-anastomotic biliary strictures following liver transplantation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ERCP

Trials testing the same drug.

Other recruiting trials for Liver Transplant Disorder

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05761483.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing